Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 290.00
+7.80 (2.76%)
Jun 27, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 8.79 billion as of June 27, 2025. Its market cap has decreased by -35.45% in one year.
Market Cap
8.79B
Enterprise Value
8.51B
Revenue
854.98M
Ranking
n/a
PE Ratio
64.51
Stock Price
290.00
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 8.79B, an increase of 2,266.11%. That is a compound annual growth rate of 28.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.21B |
| Sectra AB | 64.93B |
| Getinge AB | 50.58B |
| Asker Healthcare Group AB | 40.96B |
| Medicover AB | 35.78B |
| Camurus AB | 34.88B |
| AddLife AB | 22.31B |
| Vimian Group AB | 21.09B |